Abnormal monocyte recruitment and collateral artery formation in monocyte chemoattractant protein-1 deficient mice

被引:45
作者
Voskuil, M
Hoefer, IE
van Royen, N
Hua, J
de Graaf, S
Bode, C
Buschmann, IR
Piek, JJ
机构
[1] Acad Med Ctr, Dept Cardiol, NL-1100 DD Amsterdam, Netherlands
[2] Univ Freiburg, Dept Cardiol & Angiol, Res Grp Expt & Clin Arteriogenesis, D-7800 Freiburg, Germany
关键词
collateral circulation; cytokines; macrophages; regional blood flow;
D O I
10.1191/1358863x04vm571oa
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Monocyte chemoattractant protein 1 (MCP-1) has been shown to be effective for the stimulation of collateral artery formation in small and large animal models. The availability of a genetic knockout mouse enables evaluation of the importance of the role of MCP-1 in the natural course of collateral artery growth. In a total of 21 MCP-1 -/- as well as 13 of the appropriate genetic background controls ({129Sv/J X C57BI/6J}F1), a femoral artery ligation was performed. Subsequently, a polyethylene catheter, connected to an osmotic minipump, was inserted retrogradely into the occluded femoral artery with the tip pointing upstream. Using this technique, PBS (MCP-1 -/-: n = 13 and C57B1/6,1: n = 13) or MCP-1 (JE; MCP-1 -/-: n = 8) was delivered intra-arterially. Seven days after ligation, determination of hind limb flow was assessed by controlled tissue perfusion using differently labeled fluorescent microspheres. MCP-1 -/- mice exhibited a reduction of hind limb flow of 32.9 +/- 9.2% of the unligated hind limb, compared with 55.4 +/- 6.8% in C57B1/6J mice (p<0.01). MCP-1 -/- mice that underwent a subsequent 'rescue' treatment with MCP-1 showed a restoration of flow to a level of 47.4 +/- 9.8% (P = NS compared with PBS-treated C57B1/6J). Specific immunohistochemical staining for monocytes (MOMA-2: MCP-1 -/-, n = 5 and C57131/6J, n 5) showed a reduced number of monocytes around developing collateral arteries in the MCP-1 -/- mice. In conclusion, our data show that the absence of MCP-1 causes a strong reduction in flow restoration after femoral artery occlusion, coinciding with a reduced monocyte attraction, emphasizing the central role of this chemokine in the multifactorial process of collateral artery formation.
引用
收藏
页码:287 / 292
页数:6
相关论文
共 50 条
  • [31] Is there a role for monocyte chemoattractant protein-1 in delirium? Novel observations in elderly hip fracture patients
    Skrede K.
    Wyller T.B.
    Watne L.O.
    Seljeflot I.
    Juliebø V.
    BMC Research Notes, 8 (1)
  • [32] The effect of edaravone on plasma monocyte chemoattractant protein-1 levels in patients with acute myocardial infarction
    Nakamura, Yoshinori
    Yamada, Yoshihiro
    Shimomura, Hideki
    Nagayoshi, Yasuhiro
    Tsujita, Kenichi
    Yamashita, Takuro
    Fukuda, Masaya
    Ohba, Keisuke
    Nako, Hisato
    Ogura, Yuji
    Chitose, Tadasuke
    Yamaguchi, Munetaka
    Nagata, Takeshi
    Soejima, Hirofumi
    Kaikita, Koichi
    Sugiyama, Seigo
    Ogawa, Hisao
    JOURNAL OF CARDIOLOGY, 2009, 54 (03) : 416 - 424
  • [33] Hydrochloride pioglitazone decreases urinary monocyte chemoattractant protein-1 excretion in type 2 diabetics
    Ye, Shandong
    Zheng, Mao
    Hu, Yuanyuan
    Wu, Fengzhen
    Zhao, Lili
    Chen, Yan
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 88 (03) : 247 - 251
  • [34] Genetically Determined Levels of Circulating Cytokines and Risk of Stroke: Role of Monocyte Chemoattractant Protein-1
    Georgakis, Marios K.
    Gill, Dipender
    Rannikmaee, Kristiina
    Traylor, Matthew
    Anderson, Christopher D.
    Lee, Jin-Moo
    Kamatani, Yoichiro
    Hopewell, Jemma C.
    Worrall, Bradford B.
    Bernhagen, Juergen
    Sudlow, Cathie L. M.
    Malik, Rainer
    Dichgans, Martin
    CIRCULATION, 2019, 139 (02) : 256 - 268
  • [35] The chemokine monocyte chemoattractant protein-1/CCL2 is a promoter of breast cancer metastasis
    Yoshimura, Teizo
    Li, Chunning
    Wang, Yuze
    Matsukawa, Akihiro
    CELLULAR & MOLECULAR IMMUNOLOGY, 2023, 20 (07) : 714 - 738
  • [36] Detection of monocyte chemoattractant protein-1 receptor expression in experimental atherosclerotic lesions - An autoradiographic study
    Ohtsuki, K
    Hayase, M
    Akashi, K
    Kopiwoda, S
    Strauss, HW
    CIRCULATION, 2001, 104 (02) : 203 - 208
  • [37] Induction of circulating monocyte chemoattractant protein-1 in women with gonadotropin-releasing hormone agonist
    Matsui, Sumika
    Yasui, Toshiyuki
    Uemura, Hirokazu
    Yamamoto, Satoshi
    Matsuzaki, Toshiya
    Tsuchiya, Naoko
    Yuzurihara, Mitsutoshi
    Kase, Yoshio
    Irahara, Minoru
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2011, 90 (02) : 227 - 234
  • [38] The production of monocyte chemoattractant protein-1 (MCP-1)/CCL2 in tumor microenvironments
    Yoshimura, Teizo
    CYTOKINE, 2017, 98 : 71 - 78
  • [39] Metabolomic Alteration in Adipose Monocyte Chemotactic Protein-1 Deficient Mice Fed a High-Fat Diet
    Yan, Lin
    Rust, Bret M.
    Sundaram, Sneha
    Nielsen, Forrest H.
    NUTRITION AND METABOLIC INSIGHTS, 2024, 17
  • [40] Renal monocyte chemoattractant protein-1: an emerging universal biomarker and therapeutic target for kidney diseases?
    Tam, Frederick W. K.
    Ong, Albert C. M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 (02) : 198 - 203